Skip to main content
Erschienen in: International Urogynecology Journal 7/2019

01.07.2019 | Original Article

Perioperative adverse events in women undergoing concurrent urogynecologic and gynecologic oncology surgeries for suspected malignancy

verfasst von: Emily R. W. Davidson, Katherine Woodburn, Mariam AlHilli, Cecile A. Ferrando

Erschienen in: International Urogynecology Journal | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

This study’s objectives were to compare the incidence of adverse events after concurrent urogynecologic and gynecologic oncology surgery to gynecologic oncology surgery alone and to describe the frequency of modification in planned urogynecologic procedures. The authors hypothesized there would be no difference in major complications.

Methods

This was a retrospective matched cohort study of women who underwent concurrent surgery at a large tertiary care center between January 2004 and June 2017. Cohorts were matched by surgeon, surgery route, date, and final pathologic diagnosis. Perioperative data and postoperative adverse events classified by Clavien-Dindo grade were compared.

Results

One hundred and eight patients underwent concurrent surgeries, with 216 matched cohorts. Concurrent-case patients were more likely to be older, postmenopausal, have greater vaginal parity, have had preoperative chemotherapy, and have preoperative cardiac or pulmonary disease. There were no differences in intraoperative complications or Dindo grade ≥ 3 adverse events between groups, but there were more grade 2 adverse events in the concurrent cohort (44 vs 19%, p < 0.0001) including postoperative urinary tract infection (UTI) (26 vs 7%, p < 0.0001). Concurrent surgery remained associated with a higher incidence of grade ≥ 2 events on multivariate analysis [odds ratio (OR) 2.5, 95% confidence interval (CI) 1.5–4.2, p = 0.0004). Discharge with a urinary catheter was more frequent after concurrent cases (35 vs 2%, p < 0.0001). Planned urogynecologic procedures were modified in 10% (n = 11) of cases.

Conclusions

Concurrent surgeries have an increased incidence of minor but not serious perioperative adverse events. One in ten planned urogynecologic procedures is either modified or abandoned during combined surgeries.
Literatur
1.
Zurück zum Zitat Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, et al. Prevalence of symptomatic pelvic floor disorders in us women. JAMA. 2008;300(11):1311–6.CrossRefPubMedPubMedCentral Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J, et al. Prevalence of symptomatic pelvic floor disorders in us women. JAMA. 2008;300(11):1311–6.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Thomas SG, Sato HR, Glantz JC, Doyle PJ, Buchsbaum GM. Prevalence of symptomatic pelvic floor disorders among gynecologic oncology patients. Obstet Gynecol. 2013;122(5):976–80.CrossRefPubMed Thomas SG, Sato HR, Glantz JC, Doyle PJ, Buchsbaum GM. Prevalence of symptomatic pelvic floor disorders among gynecologic oncology patients. Obstet Gynecol. 2013;122(5):976–80.CrossRefPubMed
3.
Zurück zum Zitat Bretschneider CE, Doll KM, Bensen JT, Gehrig PA, Wu JM, Geller EJ. Prevalence of pelvic floor disorders in women with suspected gynecological malignancy: a survey-based study. Int Urogynecol J. 2016;27(9):1409–14.CrossRefPubMedPubMedCentral Bretschneider CE, Doll KM, Bensen JT, Gehrig PA, Wu JM, Geller EJ. Prevalence of pelvic floor disorders in women with suspected gynecological malignancy: a survey-based study. Int Urogynecol J. 2016;27(9):1409–14.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Doll KM, Snavely AC, Kalinowski A, Irwin DE, Bensen JT, Bae-Jump V, et al. Preoperative quality of life and surgical outcomes in gynecologic oncology patients: a new predictor of operative risk? Gynecol Oncol. 2014;133(3):546–51.CrossRefPubMedPubMedCentral Doll KM, Snavely AC, Kalinowski A, Irwin DE, Bensen JT, Bae-Jump V, et al. Preoperative quality of life and surgical outcomes in gynecologic oncology patients: a new predictor of operative risk? Gynecol Oncol. 2014;133(3):546–51.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Chase DM, Watanabe T, Monk BJ. Assessment and significance of quality of life in women with gynecologic cancer. Future Oncol. 2010;6(8):1279–87.CrossRefPubMed Chase DM, Watanabe T, Monk BJ. Assessment and significance of quality of life in women with gynecologic cancer. Future Oncol. 2010;6(8):1279–87.CrossRefPubMed
6.
Zurück zum Zitat Penson RT, Wenzel LB, Vergote I, Cella D. Quality of life considerations in gynecologic cancer. Figo 26th annual report on the results of treatment in gynecological cancer. Int J Gynecol Obstet. 2006;95(Suppl 1):S247–57.CrossRef Penson RT, Wenzel LB, Vergote I, Cella D. Quality of life considerations in gynecologic cancer. Figo 26th annual report on the results of treatment in gynecological cancer. Int J Gynecol Obstet. 2006;95(Suppl 1):S247–57.CrossRef
7.
Zurück zum Zitat Sullivan SA, Davidson ER, Bretschneider CE, Liberty AL, Geller EJ. Patient characteristics associated with treatment choice for pelvic organ prolapse and urinary incontinence. Int Urogynecol J. 2016;27(5):811–6.CrossRefPubMed Sullivan SA, Davidson ER, Bretschneider CE, Liberty AL, Geller EJ. Patient characteristics associated with treatment choice for pelvic organ prolapse and urinary incontinence. Int Urogynecol J. 2016;27(5):811–6.CrossRefPubMed
8.
Zurück zum Zitat Sutkin G, Alperin M, Meyn L, Wiesenfeld HC, Ellison R, Zyczynski HM. Symptomatic urinary tract infections after surgery for prolapse and/or incontinence. Int Urogynecol J. 2010;21(8):955–61.CrossRefPubMed Sutkin G, Alperin M, Meyn L, Wiesenfeld HC, Ellison R, Zyczynski HM. Symptomatic urinary tract infections after surgery for prolapse and/or incontinence. Int Urogynecol J. 2010;21(8):955–61.CrossRefPubMed
9.
Zurück zum Zitat Unger CA, Walters MD, Ridgeway B, Jelovsek JE, Barber MD, Paraiso MF. Incidence of adverse events after uterosacral colpopexy for uterovaginal and posthysterectomy vault prolapse. Am J Obstet Gynecol. 2015;212(5):603 e1–7.CrossRef Unger CA, Walters MD, Ridgeway B, Jelovsek JE, Barber MD, Paraiso MF. Incidence of adverse events after uterosacral colpopexy for uterovaginal and posthysterectomy vault prolapse. Am J Obstet Gynecol. 2015;212(5):603 e1–7.CrossRef
10.
Zurück zum Zitat Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: gynecologic oncology group study lap2. J Clin Oncol. 2009;27(32):5331–6.CrossRefPubMedPubMedCentral Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: gynecologic oncology group study lap2. J Clin Oncol. 2009;27(32):5331–6.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Unger CA, Paraiso MF, Jelovsek JE, Barber MD, Ridgeway B. Perioperative adverse events after minimally invasive abdominal sacrocolpopexy. Am J Obstet Gynecol. 2014;211(5):547 e1–8.CrossRef Unger CA, Paraiso MF, Jelovsek JE, Barber MD, Ridgeway B. Perioperative adverse events after minimally invasive abdominal sacrocolpopexy. Am J Obstet Gynecol. 2014;211(5):547 e1–8.CrossRef
12.
Zurück zum Zitat Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The clavien-dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–96.CrossRefPubMed Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The clavien-dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–96.CrossRefPubMed
13.
Zurück zum Zitat JMP®, Version 14. SAS Institute Inc., Cary, NC, 1989-2007. JMP®, Version 14. SAS Institute Inc., Cary, NC, 1989-2007.
15.
Zurück zum Zitat Bretschneider CE, Sheyn D, Mahajan ST, Ferrando CA. Adverse events after concurrent procedures for gynecologic malignancies and pelvic floor disorders. Obstet Gynecol. 2018;132(2):274–80.CrossRefPubMed Bretschneider CE, Sheyn D, Mahajan ST, Ferrando CA. Adverse events after concurrent procedures for gynecologic malignancies and pelvic floor disorders. Obstet Gynecol. 2018;132(2):274–80.CrossRefPubMed
Metadaten
Titel
Perioperative adverse events in women undergoing concurrent urogynecologic and gynecologic oncology surgeries for suspected malignancy
verfasst von
Emily R. W. Davidson
Katherine Woodburn
Mariam AlHilli
Cecile A. Ferrando
Publikationsdatum
01.07.2019
Verlag
Springer International Publishing
Erschienen in
International Urogynecology Journal / Ausgabe 7/2019
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-018-3772-6

Weitere Artikel der Ausgabe 7/2019

International Urogynecology Journal 7/2019 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.